MMP2 and neoplasm: When used in mice with breast cancer, PEG-FA-Lip cleaves PEG chains in response to MMP-2 in the tumor microenvironment, exposing FA to target 4 T1 cells and M2 tumor-associated macrophages (M2-TAM) at the tumor site.